111 related articles for article (PubMed ID: 20625754)
1. Roxithromycin downregulates production of CTACK/CCL27 and MIP-3α/CCL20 from epidermal keratinocytes.
Karakawa M; Komine M; Tamaki K; Ohtsuki M
Arch Dermatol Res; 2010 Dec; 302(10):763-7. PubMed ID: 20625754
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor-alpha-induced CTACK/CCL27 (cutaneous T-cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor kappaB.
Vestergaard C; Johansen C; Otkjaer K; Deleuran M; Iversen L
Cytokine; 2005 Jan; 29(2):49-55. PubMed ID: 15598438
[TBL] [Abstract][Full Text] [Related]
3. (2S)-2′-methoxykurarinone from Sophora flavescens suppresses cutaneous T cell-attracting chemokine/CCL27 expression induced by interleukin-ß/tumor necrosis factor-α via heme oxygenase-1 in human keratinocytes.
Jeong SI; Lee YE; Jang SI
J Med Food; 2010 Oct; 13(5):1116-24. PubMed ID: 20883179
[TBL] [Abstract][Full Text] [Related]
4. Diarylheptanoid hirsutenone prevents tumor necrosis factor-alpha-stimulated production of inflammatory mediators in human keratinocytes through NF-kappaB inhibition.
Lee CS; Ko HH; Seo SJ; Choi YW; Lee MW; Myung SC; Bang H
Int Immunopharmacol; 2009 Aug; 9(9):1097-104. PubMed ID: 19464389
[TBL] [Abstract][Full Text] [Related]
5. CCL27 is downregulated by interferon gamma via epidermal growth factor receptor in normal human epidermal keratinocytes.
Karakawa M; Komine M; Hanakawa Y; Tsuda H; Sayama K; Tamaki K; Ohtsuki M
J Cell Physiol; 2014 Dec; 229(12):1935-45. PubMed ID: 24710735
[TBL] [Abstract][Full Text] [Related]
6. Suppressive effects of antimycotics on tumor necrosis factor-alpha-induced CCL27, CCL2, and CCL5 production in human keratinocytes.
Kanda N; Watanabe S
Biochem Pharmacol; 2006 Aug; 72(4):463-73. PubMed ID: 16784723
[TBL] [Abstract][Full Text] [Related]
7. Roxithromycin downmodulates Th2 chemokine production by keratinocytes and chemokine receptor expression on Th2 cells: its dual inhibitory effects on the ligands and the receptors.
Kobayashi M; Shimauchi T; Hino R; Tokura Y
Cell Immunol; 2004 Mar; 228(1):27-33. PubMed ID: 15203317
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of thymus- and activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin.
Komine M; Kakinuma T; Kagami S; Hanakawa Y; Hashimoto K; Tamaki K
J Invest Dermatol; 2005 Sep; 125(3):491-8. PubMed ID: 16117790
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E(2) suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytes.
Kanda N; Mitsui H; Watanabe S
J Allergy Clin Immunol; 2004 Dec; 114(6):1403-9. PubMed ID: 15577845
[TBL] [Abstract][Full Text] [Related]
10. IL-17 suppresses TNF-alpha-induced CCL27 production through induction of COX-2 in human keratinocytes.
Kanda N; Koike S; Watanabe S
J Allergy Clin Immunol; 2005 Nov; 116(5):1144-50. PubMed ID: 16275389
[TBL] [Abstract][Full Text] [Related]
11. Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes.
Kanda N; Shibata S; Tada Y; Nashiro K; Tamaki K; Watanabe S
Eur J Immunol; 2009 Apr; 39(4):996-1006. PubMed ID: 19350575
[TBL] [Abstract][Full Text] [Related]
12. Roxithromycin suppresses involucrin expression by modulation of activator protein-1 and nuclear factor-kappaB activities of keratinocytes.
Takahashi H; Hashimoto Y; Ishida-Yamamoto A; Iizuka H
J Dermatol Sci; 2005 Sep; 39(3):175-82. PubMed ID: 16140218
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of MMP-9 production by TNFalpha in keratinocytes and its attenuation by vitamin D.
Bahar-Shany K; Ravid A; Koren R
J Cell Physiol; 2010 Mar; 222(3):729-37. PubMed ID: 20020446
[TBL] [Abstract][Full Text] [Related]
14. CCR4 and CCR10 are expressed on epidermal keratinocytes and are involved in cutaneous immune reaction.
Fujimoto S; Uratsuji H; Saeki H; Kagami S; Tsunemi Y; Komine M; Tamaki K
Cytokine; 2008 Oct; 44(1):172-8. PubMed ID: 18782672
[TBL] [Abstract][Full Text] [Related]
15. TARC augments TNF-alpha-induced CTACK production in keratinocytes.
Vestergaard C; Johansen C; Christensen U; Just H; Hohwy T; Deleuran M
Exp Dermatol; 2004 Sep; 13(9):551-7. PubMed ID: 15335355
[TBL] [Abstract][Full Text] [Related]
16. CTACK/CCL27 accelerates skin regeneration via accumulation of bone marrow-derived keratinocytes.
Inokuma D; Abe R; Fujita Y; Sasaki M; Shibaki A; Nakamura H; McMillan JR; Shimizu T; Shimizu H
Stem Cells; 2006 Dec; 24(12):2810-6. PubMed ID: 16931770
[TBL] [Abstract][Full Text] [Related]
17. Induction of cytokine (interleukin-1alpha and tumor necrosis factor-alpha) and chemokine (CCL20, CCL27, and CXCL8) alarm signals after allergen and irritant exposure.
Spiekstra SW; Toebak MJ; Sampat-Sardjoepersad S; van Beek PJ; Boorsma DM; Stoof TJ; von Blomberg BM; Scheper RJ; Bruynzeel DP; Rustemeyer T; Gibbs S
Exp Dermatol; 2005 Feb; 14(2):109-16. PubMed ID: 15679580
[TBL] [Abstract][Full Text] [Related]
18. CCL28 production in HaCaT cells was mediated by different signal pathways from CCL27.
Kagami S; Saeki H; Komine M; Kakinuma T; Nakamura K; Tsunemi Y; Sasaki K; Asahina A; Tamaki K
Exp Dermatol; 2006 Feb; 15(2):95-100. PubMed ID: 16433680
[TBL] [Abstract][Full Text] [Related]
19. Chemokine expression in human erythroid leukemia cell line AS-E2: macrophage inflammatory protein-3alpha/CCL20 is induced by inflammatory cytokines.
Inoue Y; Tsushima H; Ando K; Sawayama Y; Sakai M; Yamasaki R; Matsuo E; Tsutsumi C; Imaizumi Y; Iwanaga M; Imanishi D; Taguchi J; Miyazaki Y; Tomonaga M
Exp Hematol; 2006 Jan; 34(1):19-26. PubMed ID: 16413387
[TBL] [Abstract][Full Text] [Related]
20. Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugs.
Fernandez TD; Mayorga C; Torres MJ; Cornejo-Garcia JA; López S; Chaves P; Rondon C; Blanca M
Allergy; 2008 Jun; 63(6):712-9. PubMed ID: 18384452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
